• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vaishali Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71078.0
  • ISIN : INE972X01022
8.58 0 (4.13%)
  • As on 22 Sep 2026 (EOD)

  • Today’s Low

    8.17

  • Today’s High

    8.75

  • Open

    8.17

  • Perv Close

    8.24

  • 52W Low

    4.75

  • 52W High

    12.34

Key Indicators

  • P/E(TTM)

    26.00

  • Mar.Cap (₹Cr.)

    111.94

  • Div & Yield %

    0.00

  • Book Value(₹)

    5.29

  • Debt-Equity Ratio

    4.13

  • AGM Date

    22-Sep-2026

  • EPS

    0.33

  • P/E Ratio

    26.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    111.94

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    26.09

  • BV (₹)

    5.30

  • Sales( ₹ in Cr.)

    108.77

  • NP (in Cr.)

    4.03

  • NP Var(%)

    393.0

  • Div%

    0.0

  • CPS (₹)

    0.40

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    111.94

  • 52 Week High

    12.34

  • 52 Week Low

    4.75

  • Price BSE

    0.0

  • Price NSE

    9.00

  • Market Capital( in Cr.)

    111.94

  • P/C Ratio

    25.40

  • P/E Ratio

    29.10

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 99.03 86.28 69.66 75.82 53.77 60.09
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 99.03 86.28 69.66 75.82 53.77 60.09
Other Income 3.21 2.03 2.23 1.79 1.81 2.17
Stock Adjustments 4.43 -2.67 2.42 0.04 -0.29 -0.10
Total Income 106.67 85.64 74.31 77.65 55.29 62.16
EXPENDITURE :            
Raw Materials 90.10 71.75 57.10 63.54 45.86 50.99
Power and Fuel Cost 0.00 0.00 0.00 0.00 0.00 0.00
Employee Cost 1.58 1.40 1.30 1.36 1.19 1.27
Other Manufacturing Expenses 0.04 0.02 0.02 0.02 0.02 0.02
Selling and Administration Expenses 5.62 3.42 4.28 4.06 1.94 2.62
Miscellaneous Expenses 5.54 5.35 0.00 0.00 1.82 4.19
Employee Benefit Expenses 1.58 1.40 1.30 1.36 1.19 1.27
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 102.88 81.95 62.71 68.97 50.83 59.09
Operating Profit 3.78 3.70 11.61 8.67 4.46 3.08
Interest 2.07 2.27 2.26 2.49 2.63 2.56
Gross Profit 1.71 1.43 9.35 6.18 1.83 0.52
Depreciation 0.49 0.51 0.50 0.46 0.43 0.44
Profit Before Tax 1.22 0.92 8.85 5.72 1.40 0.08
Current Tax 0.42 0.25 2.24 1.72 0.38 0.06
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.01 -0.04 0.00 -0.02 -0.02 -0.01
Reported Net Profit 0.82 0.72 6.60 4.02 1.05 0.03
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.82 0.72 6.60 4.02 1.05 0.03
Adjustment below Net Profit 0.00 0.02 0.00 0.00 0.00 0.00
P & L Balance brought forward 15.09 14.35 7.59 3.57 2.52 2.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 15.91 15.09 14.19 7.59 3.57 2.52
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.06 0.67 6.26 3.82 0.99 0.03
Earnings Per Share(Adj)-Unit Curr 0.06 0.67 6.26 3.82 0.99 0.03
Book Value 4.98 33.41 38.43 24.99 21.26 20.27
Book Value(Adj)-Unit Curr 4.98 33.41 38.43 24.99 21.26 20.27

Shareholding Pattern

  • Promoter Group

    30.54%

  • Public Share Holding

    69.46%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 2,500,050 1.85 2,500,050 5
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 38,735,240 28.69 38,735,240 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 41,235,290 30.54 41,235,290 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 7,943,669 5.88 3,405,804 46
Clearing Members 119,655 0.09 119,655 8
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 453,677 0.34 453,677 167
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,303,768 2.45 3,303,768 327
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 45,234,589 33.51 45,234,589 93
Individuals holding nominal share capital up to Rs. 1 lakh 36,704,617 27.19 36,704,617 26,045
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 93,764,705 69.46 89,226,840 26,687
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 134,999,995 100.00 130,462,130 26,697

Company Background

Vaishali Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vaishali Pharma Ltd
  • BSE Code : 71078.0
  • ISIN : INE972X01022

  • Incorporation Year

    2008

  • Registered Office

    706 to 709 7th Floor Aravali
    Business Centre Borivali(W), Mumbai,
    Maharashtra-400092

  • Telephone

    91-22-28928833

  • FAX

    91-22-28928833

  • Chairman

    Atul Vasani

  • Managing Director

  • Company Secretary

    Vishwa Mekhia

  • Auditor

    Raman S Shah & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Vaishali Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vaishali Pharma 8.58 102.23 99.03 26.00 4.92
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77